Ebitda 更改
AbbVie USD 4.49B 2.26B 2024-03
Acadia Pharmaceuticals USD 20.74M 15.84M 2024-03
Agios Pharmaceuticals USD -90724000 14.15M 2024-03
ALKERMES USD 60.95M 30.99M 2024-03
Alnylam Pharmaceuticals USD -2848000 100.07M 2024-03
Amgen USD 2.16B 1.5B 2024-03
Biogen USD 681.5M 29.4M 2024-03
BioMarin Pharmaceutical USD 136.44M 81.36M 2024-03
Cytokinetics USD -115991000 5.09M 2024-03
Dynavax Technologies USD -8140000 2.25M 2024-03
Exelixis USD 68.68M 79.96M 2024-03
Gilead Sciences USD -3542000000 6.27B 2024-03
Halozyme Therapeutics USD 120.74M 987K 2024-03
Incyte USD 258.54M 31.54M 2024-03
Intra Cellular Therapies USD -20820000 13.14M 2024-03
Ionis Pharmaceuticals USD -116518000 113.59M 2024-03
Neurocrine Biosciences USD 41.8M 104.9M 2024-03
Pfizer USD 5.95B 4.81B 2024-03
Prothena USD -81313000 91.85M 2024-03
Regeneron Pharmaceuticals USD 830.9M 485.5M 2024-03
Repligen USD 23.8M 2.82M 2024-03
Sarepta Therapeutics USD 54.36M 64.27M 2024-03
Teva Pharmaceutical Industries USD 55M 1.63B 2024-03
Ultragenyx Pharmaceutical USD -145537000 7.63M 2024-03
Vertex Pharmaceuticals USD 1.34B 262.8M 2024-03



Neurocrine Biosciences - 当前值,历史数据,预测,统计,图表和经济日历 - Jun 2024.